Clin2
NCT03594760Possibly a fitRecruiting

PSMA PET scan study using advanced computer imaging in prostate cancer

Prostate Cancer

Treatments studied

Part of Cancer, Kidney & urinary clinical trials.

This Phase 3 study looks at how a PSMA PET scan can predict how prostate cancer will progress and how well treatment is working. If your doctor at CHUM orders this scan, you may be able to join to help refine better predictions for future patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,000 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have prostate cancer and receive care at CHUM
  • Your CHUM doctor has requested a PSMA PET scan for you
  • You can complete the imaging procedure as scheduled
  • You do not have severe claustrophobia or a way to manage it during the scan

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05520255Recruiting· Phase 3
PSMA PET/CT scan to guide care after prostate cancer treatment

This Phase 3 study checks whether a PSMA PET/CT scan (using a special tracer) can help doctors make better decisions for people with prostate cancer after treatment, based on PSA blood test changes. It may help identify whether cancer has spread or how to plan next steps.

Edmonton, Alberta
NCT06167629Recruiting
PSMA PET scan study for prostate cancer

This study uses a special type of PET scan called PSMA PET to better understand and track prostate cancer. The scan helps doctors see where the cancer is in the body and if treatment is working.

Milan
NCT06489496Not yet recruiting
Prostate cancer PSMA PET scan access trial

This study allows people with prostate cancer to get a special PET scan that finds cancer cells. The scan helps doctors plan the best treatment. You may qualify if your PSA is rising or you have high-risk prostate cancer.

NCT06099093Recruiting· Phase 4
PSMA PET scan before standard therapy for advanced prostate cancer

This trial will test if a special PET scan (18F-DCFPyL) can help doctors plan your treatment with a radioactive medicine called 177Lu-vipivotide tetraxetan. You are eligible if you already qualify for that standard therapy and have had a prior PSMA PET scan showing at least one active cancer site.

Boston, Massachusetts
NCT06696326Recruiting
New PET scan for prostate cancer detection

This study tests a new type of PET/CT scan that uses a special tracer (68Ga-MY6349) to better see prostate cancer in the body. It may help doctors find cancer that has come back or spread, so you can get the right treatment sooner.

Xiamen, Fujian
NCT06690970Recruiting
PSMA PET/CT scan for people with or suspected to have cancer

This study is looking at how well a special type of PET/CT scan (called PSMA PET/CT) can see cancer in people who have or may have certain tumors. It may help doctors better understand and track the disease.

Hefei, Anhui

Hear when a new Prostate cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.